CLICK ON THE LINKS BELOW TO READ OUR REPORTS FROM EVENTS, SURVEYS, AND EDUCATIONAL SOURCES
Canadian Cancer Society Statistics Reports – SYSF Distillation of Melanoma Data
NEW! April 2022: Canadian Cancer Society Statistics Report 2021 Recap
October 16, 2019: Melanoma Statistics – A Distillation from the 2019 Canadian Cancer Society Report And a Quick Reference: Canadian Melanoma Statistics 2019
September 2018: 2018 Canadian Melanoma Statistics
June 2017: A Distillation of Melanoma Statistics, from the Canadian Cancer Society Documents Canadian Cancer Statistics 2017 and 2016.
To read the full reports on Canadian Cancer Statistics, produced by Canadian Cancer Society, Statistics Canada, Public Health Agency of Canada, Provincial/Territorial Cancer Registries, click here for past reports.
Leger Survey 2020
A survey of adult Canadians, conducted by Leger in March 2020 in collaboration with Novartis Pharmaceuticals Canada Inc. and Save Your Skin Foundation, shows gaps in knowledge about melanoma skin cancer.
August 2021 : Ocumel Canada Patient Survey Report – Updating the OM Care Landscape in Canada, 2021
January 2021 : Ocumel Canada 2018-2020 Activity Report
September 2020: Ocumel Canada Health Care Provider Survey Report: Understanding Ocular Melanoma Care Pathways in Canada
July 2018 : Save Your Skin Foundation 2018 Ocular Melanoma Survey Report
Virtual Meeting : ASCO 2021 Report
Virtual Meeting : ASCO 2020 Report
May 31 – June 4, 2019 – Chicago, Illinois : ASCO 2019 Report
June 1-5, 2018 – Chicago, Illinois : ASCO 2018 Report
June 2-6, 2017 – Chicago, Illinois : ASCO17 Report: Important Considerations for Decision-Makers
October 2017 : SYSF Survey for World Mental Health Day – and click here to view the resulting Poster titled The Affects of Melanoma on the Mental Wellness of Patients, and the Landscape of Mental Health Support in the Canadian Melanoma Community
View all reports from annual: Patients Redefining the Future of Health Care in Canada Summit
Every year Save Your Skin Foundation provides hundreds of Canadians with melanoma and non-melanoma skin cancer with information about drug trials and new treatment options. They collaborate with health technology assessments and government bodies to push for timely and equal access to new treatments.
